Opaleye Management Inc. - Insider Trading & Ownership

Entity
Company
Location
One Boston Place, Suite 2600, Boston, Massachusetts
Summary
The estimated value of insider holdings of Opaleye Management Inc. is at least $59.6 M dollars as of July 3, 2024. Opaleye Management Inc. is the 10%+ Owner of HARROW, INC. and owns shares of HARROW, INC. (HROW) stock worth about $38 M. Opaleye Management Inc. is the Former 10% Owner. of TELA Bio, Inc. and owns shares of TELA Bio, Inc. (TELA) stock worth about $11.7 M. Opaleye Management Inc. is the 10%+ Owner of Eton Pharmaceuticals, Inc. and owns shares of Eton Pharmaceuticals, Inc. (ETON) stock worth about $5 M. Opaleye Management Inc. is the 10%+ Owner of Protara Therapeutics, Inc. and owns shares of Protara Therapeutics, Inc. (TARA) stock worth about $4.89 M.
All Insider Reports
All Insider Reports

Ownership of Opaleye Management Inc.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
HROW, HROWL HARROW, INC. 10%+ Owner $38 M +$2.34 M +6.55% Apr 25, 2024
TELA TELA Bio, Inc. Former 10% Owner. $11.7 M Apr 20, 2023
ETON Eton Pharmaceuticals, Inc. 10%+ Owner $5 M Nov 17, 2021
TARA Protara Therapeutics, Inc. 10%+ Owner $4.89 M -$1.16 M -19.2% Jul 1, 2024
TCON Tracon Pharmaceuticals, Inc. 10%+ Owner -$1.4 M Nov 10, 2023

Insider Transactions Reported by Opaleye Management Inc.:

Sym Company Class Transaction % Value $ Price $ Shares Shares After Date Ownership